Multidisciplinary reconstructive management of residual recalcitrant empyema cavity: A retrospective observational cohort study.

Luke Ce Allen, Richard Milton, Grainne Bourke

Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2022;75(3):1057-1063

PMID: 34872875

Abstract

BACKGROUND

Patients with stage III empyema require chest wall fenestration to enable lung re-expansion and continuous drainage of the persisting empyema cavity. This chronic wound negatively affects patients' exercise tolerance, ability to carry out activities of daily living, and quality of life.

METHODS

Eight consecutive patients underwent chest wall reconstruction following fenestration and were followed up over a minimum of 12 months. This study included adult patients (over 18 years of age). There were no exclusion criteria. Data were collected retrospectively.

RESULTS

Eight patients (six male and two female), with a mean age of 56 years (range, 22-76), were included. All of them had comorbidities including history of neoplasia (n = 6), atrial fibrillation (n = 3), and hypertension (n = 2). Aetiology of empyema included lung cancer resection complicated by bronchopleural fistula (n = 4), pneumonia (n = 2), and pleural effusion (n = 2). Five patients had a low metabolic reserve evident by a low BMI (range, 16-22), and a median malnutrition universal screen tool (MUST) score of 2 (range, 1-4). Following intensive infection control and nutritional support, patients underwent reconstruction 11 months (median; range 5-51) after fenestration. Seven patients were followed up and had no recurrence of empyema and bronchopleural fistula. They all reported significant improvements in their quality of life, and their Eastern Cooperative Oncology Group (ECOG) performance status improved from three to one. One patient died 56 days post-reconstruction from cardiorespiratory failure, which required readmission to hospital.

CONCLUSION

We demonstrate that free tissue reconstruction including multidisciplinary input and optimisation at all stages of care successfully closes residual recalcitrant empyema cavity without recurrence and leads to significant improvements in the quality of life.

Crown Copyright © 2021. Published by Elsevier Ltd. All rights reserved.

Address: Leeds School of Medicine, Faculty of Medicine and Health Sciences, University of Leeds, Leeds LS2 9NL, UK. Electronic address: [email protected].; Department of Thoracic Surgery, Leeds Teaching Hospitals Trust, Leeds LS9 7TF, UK.; Leeds School of Medicine, Faculty of Medicine and Health Sciences, University of Leeds, Leeds LS2 9NL, UK; Department of Plastic and Reconstructive Surgery, Leeds Teaching Hospitals Trust, Leeds LS9 7TF, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.